Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery
NCT01898598 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 23, 2014
- Completion date
- January 26, 2016
- Enrollment
- 18 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.